成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Shanghaizehan biopharma technology co., Ltd.??? ?? ??? ?????.

?? ?:Shanghaizehan biopharma technology co., Ltd.
??:021-61350663
???:sales@zehanbiopharma.com
??:China
URL: http://www.zehanbiopharma.com
? ?? ?:1009
4 5 6 7 8 9 10 11

?? ????

PLX4032 (Vemurafenib)918504-65-1C23H18ClF2N3O3S
AK120765955272-06-7C19H15ClN4O2
ETP-463211252594-99-2C20H27N9O3S
Grapiprant??????415903-37-6C26H29N5O3S
Lasmiditan hydrochloride613677-28-4C19H19ClF3N3O2
DM1-SMe138148-68-2C36H50ClN3O10S2
MKC39461093119-54-0C21H20N2O3S
DMU21051031063-36-1C18H13NO
JAK3-IN-61443235-95-7C19H18N4O3
4-ACRYLAMIDOBENZO-18-CROWN-6, 9868865-32-7C19H27NO7
GSK0462474876-09-8C23H27FN2O4
Datelliptium chloride????105118-14-7
Fatostatin A Hydrobromide298197-04-3C18H19BrN2S
SI-60133152-67-7C18H17F6OSSb
CPI-6371884712-47-3C22H22N6O
Acebilustat???????943764-99-6C29H27N3O4
UK-371804??-371804256477-09-5C14H16ClN5O4S
Compound A1665301-36-9C47H63ClN4O14S
MRT68921 HCI2070014-87-6C25H35ClN6O
Tegobuvir1000787-75-6C25H14F7N5
Aripiprazole Dimer Impurity1797986-18-5C48H56Cl4N6O4
CK869388592-44-7C17H16BrNO3S
PEO-IAA6266-66-6C18H15NO3
CNV 1014802 hydrochlorideCNV1014802(???)934240-31-0C18H20ClFN2O2
ACY-7752-[1-(3-????-??)-?????????]-????-5-????????????1375466-18-4C17H19FN4O2
PF-4878691532959-63-0C17H23N5O2S
mTOR inhibitor-1468747-17-3C16H15BrN2O3
AC5216226954-04-7C23H23N5O2
CHIR-98014252935-94-7C20H17Cl2N9O2
XMD 8-921234480-50-2C26H30N6O3
WH-4-023837422-57-8C32H36N6O4
Onatasertib(CC 223,ATG-008)1228013-30-6C21H27N5O3
EPZ015866,GSK32035911616391-87-7C22H28N4O2
BDA-3661909226-00-1C24H29N3O4
Lys-SMCC-DM11281816-04-3C53H75ClN6O15S
yGsy2p-IN-12415003-97-1C16H11F3N2O4
PF-573228869288-64-2C22H20F3N5O3S
Motolimod (VTX-2337)926927-61-9C28H34N4O2
SGI 10271020149-73-8C27H23N7O
Ellipticine hydrochloride5081-48-1C17H15ClN2
AF643941637300-25-4C21H20ClN5O
Vipadenant(BIIB-014)????442908-10-3C16H15N7O
GSK189254A720690-73-3C21H25N3O2
KN92 phosphateKN92???1135280-28-2C24H28ClN2O7PS
SUN11602704869-38-5C26H37N5O2
SHP0991801747-42-1C16H19Cl2N5
Seclidemstat1423715-37-0C20H23ClN4O4S
GLX351322835598-94-2C21H25N3O5S
Lersivirine(UK 453061)473921-12-9C17H18N4O2
CHIR-090728865-23-4C24H27N3O5
Voxtalisib (XL765, SAR245409)934493-76-2C13H14N6O
PFI-31819363-80-8C19H19N3O2
MS0231831110-54-3C17H25N3O
XMU-MP-12061980-01-4C17H16N6O3S2
MK-4101935273-79-3C24H24F5N5O
NVS-PAK1-11783816-74-9C23H25ClF3N5O
SBI-115882366-16-7C14H13ClN2O4S
SSE152061370046-40-4C19H21N3O3S
ZM2232031177-48-5C23H17F3N4O2S2
GW2580870483-87-7C20H22N4O3
Lasmiditan?????439239-90-4C19H18F3N3O2
PF03274167900510-03-4C19H19ClFN5O3
UNC12151415800-43-9C32H43N5O2
CWHM-121564286-55-0C26H32BrN5O6
Defactinib hydrochloridePF04554878???1073160-26-5C20H22ClF3N8O3S
Voxelotor(GBT440, GTx011)1446321-46-5C19H19N3O3
5-chloro-2,3-dihydro-benzofuran-3-ol5590-44-3C8H7ClO2
BAY-8761799753-84-6C24H16F4N6O2
AMG-39691361224-53-4C21H20F6N4O3S
XMD-17-511628614-50-5C21H24N8O
AC 55541916170-19-9C25H20BrN5O3
CB-1035-???-2-(4-tert-?????)???218457-67-1C15H18N2O
AS1517499919486-40-1C20H20ClN5O2
ON12313201312471-39-8C22H15F2N5O3S
Lanraplenib (GS-9876)1800046-95-0C23H25N9O
MRT 68921 dihydrochloride2080306-21-2C25H35ClN6O
CP-6097541190094-64-4C29H22ClN3O2
WAY-181187(SAX-187)??181187554403-49-5C15H13ClN4O2S2
SH-4-541456632-40-8C29H27F5N2O5S
ABT-6391235560-28-7C20H20ClF2N3O3S
GDC-00841382979-44-3C18H22N8O2
GNE-35111496581-76-0C23H26F2N6O
MD2-IN-1111797-22-9C20H22O6
(+/-)-BAY K 864471145-03-4C16H15F3N2O4
ERK5-IN-21888305-96-1C17H11BrFN3O2
J-141043854-13-2C28H25ClN4O2S
Elacridar143664-11-3C34H33N3O5
metipranolol??????22664-55-7C17H27NO4
Pexmetinib (ARRY-614)945614-12-0C31H33FN6O3
LACS-139092160546-07-4C17H18Cl2N6
SJA710-61397255-09-2C22H20BrFN4
STK16-IN-11223001-53-3C17H12FN3O
Amifloxacin86393-37-5C16H19FN4O3
TRPM8 antagonist 2259674-19-6C26H26N2O2
5-CHLORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINE5-???-2,3-?????-????-3-???769-21-1C8H8ClNO
IDF-117741429054-28-3C23H32N2O2
4-(Chloromethyl)-2,6-dimethylpyridine???,4-(?????)-2,6-???-(9CI)120739-87-9C8H10ClN
TRi-1246020-68-6C12H9ClN2O5S
DMU2139104890-70-2C19H15NO2
Blu-263
4 5 6 7 8 9 10 11
Copyright 2019 ? ChemicalBook. All rights reserved